 | • レポートコード：MRC2-11QY12522 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は脂肪肉腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、外科療法）市場規模、用途別（病院、専門クリニック、がん治療・リハビリテーションセンター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別脂肪肉腫治療の競争状況、市場シェア ・世界の脂肪肉腫治療市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、外科療法） ・世界の脂肪肉腫治療市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、外科療法） ・世界の脂肪肉腫治療市場：用途別市場規模 2015年-2020年（病院、専門クリニック、がん治療・リハビリテーションセンター） ・世界の脂肪肉腫治療市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、がん治療・リハビリテーションセンター） ・北米の脂肪肉腫治療市場分析：米国、カナダ ・ヨーロッパの脂肪肉腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの脂肪肉腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の脂肪肉腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの脂肪肉腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Pfizer、Eli Lilly、Sanofi SA、Novartis AG、Baxter International、Bristol Laboratories、Teva Pharmaceutical Industries、Mylan N.V、Actavis、Fresenius Kabi、Accord Healthcare、Taro Pharmaceuticals、Sandoz、Bedford Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs.
Surgical therapy treatment segment is expected to account for major share in global liposarcoma treatment market as it is the choice of treatment recommended by majority of cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma treatment however, it can be used prior to the surgery to reduce the size of the tumor making it the second largest segment in terms of value in global liposarcoma treatment market. Radiation therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a minimal share in global liposarcoma treatment market.
Market Analysis and Insights: Global Liposarcoma Treatment Market
The global Liposarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Liposarcoma Treatment Scope and Market Size
Liposarcoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liposarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Pfizer
Eli Lilly
Sanofi SA
Novartis AG
Baxter International
Bristol Laboratories
Teva Pharmaceutical Industries
Mylan N.V
Actavis
Fresenius Kabi
Accord Healthcare
Taro Pharmaceuticals
Sandoz
Bedford Laboratories
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Surgical Therapy
Market segment by Application, split into
Hospitals
Multispecialty Clinics
Cancer Treatment and Rehabilitation Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liposarcoma Treatment Revenue
1.4 Market by Type
1.4.1 Global Liposarcoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Surgical Therapy
1.5 Market by Application
1.5.1 Global Liposarcoma Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Multispecialty Clinics
1.5.4 Cancer Treatment and Rehabilitation Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Liposarcoma Treatment Market Perspective (2015-2026)
2.2 Global Liposarcoma Treatment Growth Trends by Regions
2.2.1 Liposarcoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liposarcoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Liposarcoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Liposarcoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Liposarcoma Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Liposarcoma Treatment Players by Market Size
3.1.1 Global Top Liposarcoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Liposarcoma Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Liposarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liposarcoma Treatment Market Concentration Ratio
3.2.1 Global Liposarcoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liposarcoma Treatment Revenue in 2019
3.3 Liposarcoma Treatment Key Players Head office and Area Served
3.4 Key Players Liposarcoma Treatment Product Solution and Service
3.5 Date of Enter into Liposarcoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Liposarcoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Liposarcoma Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Liposarcoma Treatment Market Size by Application (2015-2020)
5.2 Global Liposarcoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Liposarcoma Treatment Market Size (2015-2020)
6.2 Liposarcoma Treatment Key Players in North America (2019-2020)
6.3 North America Liposarcoma Treatment Market Size by Type (2015-2020)
6.4 North America Liposarcoma Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Liposarcoma Treatment Market Size (2015-2020)
7.2 Liposarcoma Treatment Key Players in Europe (2019-2020)
7.3 Europe Liposarcoma Treatment Market Size by Type (2015-2020)
7.4 Europe Liposarcoma Treatment Market Size by Application (2015-2020)
8 China
8.1 China Liposarcoma Treatment Market Size (2015-2020)
8.2 Liposarcoma Treatment Key Players in China (2019-2020)
8.3 China Liposarcoma Treatment Market Size by Type (2015-2020)
8.4 China Liposarcoma Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Liposarcoma Treatment Market Size (2015-2020)
9.2 Liposarcoma Treatment Key Players in Japan (2019-2020)
9.3 Japan Liposarcoma Treatment Market Size by Type (2015-2020)
9.4 Japan Liposarcoma Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Liposarcoma Treatment Market Size (2015-2020)
10.2 Liposarcoma Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liposarcoma Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Liposarcoma Treatment Market Size by Application (2015-2020)
11 India
11.1 India Liposarcoma Treatment Market Size (2015-2020)
11.2 Liposarcoma Treatment Key Players in India (2019-2020)
11.3 India Liposarcoma Treatment Market Size by Type (2015-2020)
11.4 India Liposarcoma Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Liposarcoma Treatment Market Size (2015-2020)
12.2 Liposarcoma Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Liposarcoma Treatment Market Size by Type (2015-2020)
12.4 Central & South America Liposarcoma Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Liposarcoma Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Liposarcoma Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Liposarcoma Treatment Introduction
13.2.4 Pfizer Revenue in Liposarcoma Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Liposarcoma Treatment Introduction
13.3.4 Eli Lilly Revenue in Liposarcoma Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Sanofi SA
13.4.1 Sanofi SA Company Details
13.4.2 Sanofi SA Business Overview
13.4.3 Sanofi SA Liposarcoma Treatment Introduction
13.4.4 Sanofi SA Revenue in Liposarcoma Treatment Business (2015-2020)
13.4.5 Sanofi SA Recent Development
13.5 Novartis AG
13.5.1 Novartis AG Company Details
13.5.2 Novartis AG Business Overview
13.5.3 Novartis AG Liposarcoma Treatment Introduction
13.5.4 Novartis AG Revenue in Liposarcoma Treatment Business (2015-2020)
13.5.5 Novartis AG Recent Development
13.6 Baxter International
13.6.1 Baxter International Company Details
13.6.2 Baxter International Business Overview
13.6.3 Baxter International Liposarcoma Treatment Introduction
13.6.4 Baxter International Revenue in Liposarcoma Treatment Business (2015-2020)
13.6.5 Baxter International Recent Development
13.7 Bristol Laboratories
13.7.1 Bristol Laboratories Company Details
13.7.2 Bristol Laboratories Business Overview
13.7.3 Bristol Laboratories Liposarcoma Treatment Introduction
13.7.4 Bristol Laboratories Revenue in Liposarcoma Treatment Business (2015-2020)
13.7.5 Bristol Laboratories Recent Development
13.8 Teva Pharmaceutical Industries
13.8.1 Teva Pharmaceutical Industries Company Details
13.8.2 Teva Pharmaceutical Industries Business Overview
13.8.3 Teva Pharmaceutical Industries Liposarcoma Treatment Introduction
13.8.4 Teva Pharmaceutical Industries Revenue in Liposarcoma Treatment Business (2015-2020)
13.8.5 Teva Pharmaceutical Industries Recent Development
13.9 Mylan N.V
13.9.1 Mylan N.V Company Details
13.9.2 Mylan N.V Business Overview
13.9.3 Mylan N.V Liposarcoma Treatment Introduction
13.9.4 Mylan N.V Revenue in Liposarcoma Treatment Business (2015-2020)
13.9.5 Mylan N.V Recent Development
13.10 Actavis
13.10.1 Actavis Company Details
13.10.2 Actavis Business Overview
13.10.3 Actavis Liposarcoma Treatment Introduction
13.10.4 Actavis Revenue in Liposarcoma Treatment Business (2015-2020)
13.10.5 Actavis Recent Development
13.11 Fresenius Kabi
10.11.1 Fresenius Kabi Company Details
10.11.2 Fresenius Kabi Business Overview
10.11.3 Fresenius Kabi Liposarcoma Treatment Introduction
10.11.4 Fresenius Kabi Revenue in Liposarcoma Treatment Business (2015-2020)
10.11.5 Fresenius Kabi Recent Development
13.12 Accord Healthcare
10.12.1 Accord Healthcare Company Details
10.12.2 Accord Healthcare Business Overview
10.12.3 Accord Healthcare Liposarcoma Treatment Introduction
10.12.4 Accord Healthcare Revenue in Liposarcoma Treatment Business (2015-2020)
10.12.5 Accord Healthcare Recent Development
13.13 Taro Pharmaceuticals
10.13.1 Taro Pharmaceuticals Company Details
10.13.2 Taro Pharmaceuticals Business Overview
10.13.3 Taro Pharmaceuticals Liposarcoma Treatment Introduction
10.13.4 Taro Pharmaceuticals Revenue in Liposarcoma Treatment Business (2015-2020)
10.13.5 Taro Pharmaceuticals Recent Development
13.14 Sandoz
10.14.1 Sandoz Company Details
10.14.2 Sandoz Business Overview
10.14.3 Sandoz Liposarcoma Treatment Introduction
10.14.4 Sandoz Revenue in Liposarcoma Treatment Business (2015-2020)
10.14.5 Sandoz Recent Development
13.15 Bedford Laboratories
10.15.1 Bedford Laboratories Company Details
10.15.2 Bedford Laboratories Business Overview
10.15.3 Bedford Laboratories Liposarcoma Treatment Introduction
10.15.4 Bedford Laboratories Revenue in Liposarcoma Treatment Business (2015-2020)
10.15.5 Bedford Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Liposarcoma Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Liposarcoma Treatment Revenue
Table 3. Ranking of Global Top Liposarcoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liposarcoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Surgical Therapy
Table 8. Global Liposarcoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Liposarcoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Liposarcoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Liposarcoma Treatment Market Share by Regions (2015-2020)
Table 12. Global Liposarcoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Liposarcoma Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Liposarcoma Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Liposarcoma Treatment Players
Table 19. Global Liposarcoma Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Liposarcoma Treatment Market Share by Players (2015-2020)
Table 21. Global Top Liposarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposarcoma Treatment as of 2019)
Table 22. Global Liposarcoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Liposarcoma Treatment Product Solution and Service
Table 25. Date of Enter into Liposarcoma Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Liposarcoma Treatment Market Size Share by Type (2015-2020)
Table 29. Global Liposarcoma Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Liposarcoma Treatment Market Size Share by Application (2015-2020)
Table 31. Global Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Liposarcoma Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 35. North America Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Liposarcoma Treatment Market Share by Type (2015-2020)
Table 37. North America Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Liposarcoma Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 41. Europe Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Liposarcoma Treatment Market Share by Type (2015-2020)
Table 43. Europe Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Liposarcoma Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 47. China Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Liposarcoma Treatment Market Share by Type (2015-2020)
Table 49. China Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Liposarcoma Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 53. Japan Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Liposarcoma Treatment Market Share by Type (2015-2020)
Table 55. Japan Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Liposarcoma Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 59. Southeast Asia Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Liposarcoma Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Liposarcoma Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 65. India Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Liposarcoma Treatment Market Share by Type (2015-2020)
Table 67. India Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Liposarcoma Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Liposarcoma Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Liposarcoma Treatment Market Share (2019-2020)
Table 71. Central & South America Liposarcoma Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Liposarcoma Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Liposarcoma Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Liposarcoma Treatment Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Product
Table 78. Johnson & Johnson Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 79. Johnson & Johnson Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Eli Lilly Company Details
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Product
Table 88. Eli Lilly Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 89. Eli Lilly Recent Development
Table 90. Sanofi SA Company Details
Table 91. Sanofi SA Business Overview
Table 92. Sanofi SA Product
Table 93. Sanofi SA Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 94. Sanofi SA Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Product
Table 98. Novartis AG Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 99. Novartis AG Recent Development
Table 100. Baxter International Company Details
Table 101. Baxter International Business Overview
Table 102. Baxter International Product
Table 103. Baxter International Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 104. Baxter International Recent Development
Table 105. Bristol Laboratories Company Details
Table 106. Bristol Laboratories Business Overview
Table 107. Bristol Laboratories Product
Table 108. Bristol Laboratories Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 109. Bristol Laboratories Recent Development
Table 110. Teva Pharmaceutical Industries Business Overview
Table 111. Teva Pharmaceutical Industries Product
Table 112. Teva Pharmaceutical Industries Company Details
Table 113. Teva Pharmaceutical Industries Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 114. Teva Pharmaceutical Industries Recent Development
Table 115. Mylan N.V Company Details
Table 116. Mylan N.V Business Overview
Table 117. Mylan N.V Product
Table 118. Mylan N.V Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 119. Mylan N.V Recent Development
Table 120. Actavis Company Details
Table 121. Actavis Business Overview
Table 122. Actavis Product
Table 123. Actavis Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 124. Actavis Recent Development
Table 125. Fresenius Kabi Company Details
Table 126. Fresenius Kabi Business Overview
Table 127. Fresenius Kabi Product
Table 128. Fresenius Kabi Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 129. Fresenius Kabi Recent Development
Table 130. Accord Healthcare Company Details
Table 131. Accord Healthcare Business Overview
Table 132. Accord Healthcare Product
Table 133. Accord Healthcare Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 134. Accord Healthcare Recent Development
Table 135. Taro Pharmaceuticals Company Details
Table 136. Taro Pharmaceuticals Business Overview
Table 137. Taro Pharmaceuticals Product
Table 138. Taro Pharmaceuticals Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 139. Taro Pharmaceuticals Recent Development
Table 140. Sandoz Company Details
Table 141. Sandoz Business Overview
Table 142. Sandoz Product
Table 143. Sandoz Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 144. Sandoz Recent Development
Table 145. Bedford Laboratories Company Details
Table 146. Bedford Laboratories Business Overview
Table 147. Bedford Laboratories Product
Table 148. Bedford Laboratories Revenue in Liposarcoma Treatment Business (2015-2020) (Million US$)
Table 149. Bedford Laboratories Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liposarcoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Surgical Therapy Features
Figure 5. Global Liposarcoma Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Multispecialty Clinics Case Studies
Figure 8. Cancer Treatment and Rehabilitation Centers Case Studies
Figure 9. Liposarcoma Treatment Report Years Considered
Figure 10. Global Liposarcoma Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Liposarcoma Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Liposarcoma Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Liposarcoma Treatment Market Share by Players in 2019
Figure 15. Global Top Liposarcoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposarcoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Liposarcoma Treatment Revenue in 2019
Figure 17. North America Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Liposarcoma Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
転移性がん治療の世界市場（～2026年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 軟骨肉腫治療の世界市場（～2026年） Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of …
- 非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 非黒色腫皮膚がん治療の世界市場（～2026年） Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlike…
- 去勢抵抗性前立腺がん治療の世界市場（～2026年） Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose a…